Drug Prices After Patent Expirations in High-Income Countries and Implications for Cost-Effectiveness Analyses von Serra-Burriel, Miquel, Martin-Bassols, Nicolau, Perényi, Gellért, Vokinger, Kerstin N

Volltext

Investments in Research and Development for Supplemental Drug Indications—Implications for Drug Price Negotiations von Vokinger, Kerstin N., Perényi, Gellért, Wouters, Olivier J.

Volltext

Variant Specific Treatment Effects with Applications in Vaccine Studies von Perenyi, Gellert, Stensrud, Mats J

Volltext bestellen

Variant Specific Treatment Effects with Applications in Vaccine Studies von Gellert Perenyi, Stensrud, Mats J

Volltext

Investments in Research and Development for Supplemental Drug Indications—Implications for Drug Price Negotiations von Vokinger, Kerstin N, Perényi, Gellért, Wouters, Olivier J

Volltext

The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectio... von Vokinger, Kerstin N, Serra-Burriel, Miquel, Laube, Yannic, Perényi, Gellért, Mitchell, Aaron P

Volltext

The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectio... von Miquel Serra-Burriel, Gellért Perényi, Yannic Laube, Aaron P. Mitchell, Kerstin N. Vokinger

Volltext

The cancer premium – explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a cross sectio... von Serra-Burriel, Miquel, Perényi, Gellért, Laube, Yannic, Mitchell, Aaron P., Vokinger, Kerstin N.

Volltext